Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis

Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis

Introduction: The mesenchymal-epithelial transition factor (c-MET) receptor is overexpressed in about 14–54% of invasive breast cancers, but its prognostic value in clinical practice is still unclear. Methods: In order to investigate the relationship between c-MET expression levels and prognosis, we...

Full description

Bibliographic Details
Main Authors: Francesco Iovino, Anna Diana, Francesca Carlino, Franca Ferraraccio, Giuliano Antoniol, Francesca Fisone, Alessandra Perrone, Federica Zito Marino, Iacopo Panarese, Madhura S. Tathode, Michele Caraglia, Gianluca Gatta, Roberto Ruggiero, Simona Parisi, Ferdinando De Vita, Fortunato Ciardiello, Ludovico Docimo, Michele Orditura
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Clinical Medicine
Subjects:
biomarkers
early breast cancer
hepatocyte growth factor receptor
c-MET
Online Access:https://www.mdpi.com/2077-0383/11/23/6987

Internet

https://www.mdpi.com/2077-0383/11/23/6987

Similar Items